Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

Bone Marrow Transplantation
K van BesienR Champlin

Abstract

Donor lymphocyte infusions, by virtue of a graft-versus-tumor effect, have been shown to induce remissions in leukemia that recurs after allogeneic bone marrow transplantation. Similar effects have been postulated to contribute to the decreased recurrence rate observed after allogeneic transplantation in non-Hodgkin's lymphoma. This lower recurrence rate may be due to a variety of other mechanisms. We aimed to evaluate the role of graft-versus-lymphoma effects in patients in whom lymphomas recur after allogeneic transplantation. At the time of recurrence, immunosuppressive therapy was withheld. Patients with non-responding disease received an infusion of donor lymphocytes. Patients were observed for response and graft-versus-host disease. Disease in four of nine patients responded to withdrawal of immunosuppressive therapy. A minor response was observed in one of three recipients of donor lymphocyte infusions. Responses were observed among two patients with follicular lymphoma, one with large cell lymphoma and one with lymphoblastic lymphoma. A minor response was observed in a patient with prolymphocytic leukemia/lymphoma. We conclude that withdrawal of immunosuppressive therapy and donor lymphocyte infusion can induce durable ...Continue Reading

Citations

Aug 29, 2003·Current Treatment Options in Oncology·Sonali M Smith
Aug 19, 2006·Current Treatment Options in Oncology·Sonali M Smith
Oct 1, 2007·Current Hematologic Malignancy Reports·Constantine S Tam, Issa Khouri
Aug 8, 2001·Current Oncology Reports·B M Hayes-LattinT M Beer
Aug 19, 2008·Current Oncology Reports·Vaishalee Padgaonkar Kenkre, Sonali M Smith
Jul 5, 2003·Experimental Hematology·Imad A Tabbara, Richard M Ingram
Jun 26, 1999·Biochimica Et Biophysica Acta·J G Gribben
Sep 10, 2003·Seminars in Cancer Biology·Jürgen Finke
May 17, 2005·Bone Marrow Transplantation·B W Butcher, R H Collins
Nov 20, 2002·Vox Sanguinis·P H Roddie, M L Turner
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·F Baron, Y Beguin
Aug 8, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R BishopD H Fowler
Aug 23, 2002·Current Opinion in Oncology·Karen E Kogel, Peter A McSweeney
Aug 9, 2001·Current Opinion in Urology·R Childs, D Drachenberg
Nov 5, 1999·Current Opinion in Hematology·A Krackhardt, J G Gribben
Dec 16, 2010·Current Opinion in Oncology·Nicolaus Kröger
Sep 29, 2011·Current Opinion in Oncology·Koen van Besien
Oct 10, 2013·Current Opinion in Hematology·Andrew R Rezvani, Brenda M Sandmaier
Sep 26, 2012·The Cancer Journal·Issa F Khouri, Richard E Champlin
Jan 11, 2005·British Journal of Haematology·Karl S PeggsDavid C Linch
Mar 12, 1999·Annual Review of Medicine·D L Porter, J H Antin
Jan 30, 2004·Annual Review of Medicine·Richard W Childs, John Barrett
Feb 13, 2001·European Journal of Haematology·L Vindeløv
Feb 13, 2001·European Journal of Haematology·L GarderetE Gluckman
May 4, 2010·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Frank HeinzelmannMartin Weinmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.